Sato S - Search Results

1

Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements.

Kuwana M, Bando M, Kawahito Y, Sato S, Suda T, Kondoh Y; CTD-ILD Delphi Collaborators. Kuwana M, et al. Among authors: sato s. Expert Rev Respir Med. 2023 Jan;17(1):71-80. doi: 10.1080/17476348.2023.2176303. Epub 2023 Feb 20. Expert Rev Respir Med. 2023. PMID: 36786105 Free article.

2

Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.

Sato S, Ohosone Y, Suwa A, Yasuoka H, Nojima T, Fujii T, Kuwana M, Nakamura K, Mimori T, Hirakata M. Sato S, et al. J Rheumatol. 2003 Dec;30(12):2673-9. J Rheumatol. 2003. PMID: 14719212 Clinical Trial.

3

Association between autoantibodies to the Ku protein and DPB1*.

Hirakata M, Suwa A, Kuwana M, Sato S, Mimori T, Hardin JA. Hirakata M, et al. Among authors: sato s. Arthritis Rheum. 2005 Feb;52(2):668-9. doi: 10.1002/art.20766. Arthritis Rheum. 2005. PMID: 15693000 Free article. No abstract available.

4

Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis.

Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, Nishikawa T, Oddis CV, Ikeda Y. Sato S, et al. Arthritis Rheum. 2005 May;52(5):1571-6. doi: 10.1002/art.21023. Arthritis Rheum. 2005. PMID: 15880816 Free article.

5

Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.

Sato S, Takada T, Katsuki Y, Kimura N, Kaneko Y, Suwa A, Hirakata M, Kuwana M. Sato S, et al. J Rheumatol. 2008 Jan;35(1):142-6. Epub 2007 Nov 15. J Rheumatol. 2008. PMID: 18050368 Clinical Trial.

6

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease.

Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, Kuwana M. Sato S, et al. Arthritis Rheum. 2009 Jul;60(7):2193-200. doi: 10.1002/art.24621. Arthritis Rheum. 2009. PMID: 19565506 Free article.

7

Clinically amyopathic dermatomyositis.

Sato S, Kuwana M. Sato S, et al. Curr Opin Rheumatol. 2010 Nov;22(6):639-43. doi: 10.1097/BOR.0b013e32833f1987. Curr Opin Rheumatol. 2010. PMID: 20827200 Review.

8

Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies.

Sato S, Kuwana M, Fujita T, Suzuki Y. Sato S, et al. Mod Rheumatol. 2012 Aug;22(4):625-9. doi: 10.1007/s10165-011-0558-9. Epub 2011 Nov 29. Mod Rheumatol. 2012. PMID: 22124544

9

Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis.

Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y, Takagi K, Baba S, Okamoto Y, Ota Y, Yamanaka H. Gono T, et al. Among authors: sato s. Rheumatology (Oxford). 2012 Sep;51(9):1563-70. doi: 10.1093/rheumatology/kes102. Epub 2012 May 15. Rheumatology (Oxford). 2012. PMID: 22589330

10

Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease.

Sato S, Kuwana M, Fujita T, Suzuki Y. Sato S, et al. Mod Rheumatol. 2013 May;23(3):496-502. doi: 10.1007/s10165-012-0663-4. Epub 2012 May 29. Mod Rheumatol. 2013. PMID: 22644102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,299 results

Search Page

Filters